Call Today:
 

Tel: +1 (844) 792-6300

Address:
 
Thrombolex, Inc.
75 Britain Drive

New Britain, PA 18901​

  • Facebook - White Circle
  • Twitter - White Circle
  • Instagram - White Circle
  • LinkedIn - White Circle

© 2019 by Thrombolex™   |   All Rights Reserved    |    Disclaimers    

Home / John Cerminaro

Leadership
John Cerminaro,
Chief Financial Officer

 

john@thrombolex.com

Mr. Cerminaro directs the financial, accounting, and fiscal affairs of the company and assists the executive leadership team with operational strategy implementation. He has extensive experience in finance, accounting, and operational strategy development and implementation.

 

Mr. Cerminaro was formerly the Chief Financial Officer for the Parker Health Group and held the role of Chief Investment Officer of the $1.4 billion Parker endowment. Mr. Cerminaro has held Chief Financial Officer roles at a number of private equity and financial services firms throughout his career.

 

He received his undergraduate degree with a major in management information systems from the SUNY Institute of Technology and received an MBA in finance and accounting from the University of Illinois.

Change for the Better

“ I am convinced this will change the treatment of VTE for the better across-the-board. It’s an approach that will not only save lives but save healthcare costs in the process.

                               

                   -  John Cerminaro:  

                       Chief Financial Officer

Available Now:

The BASHIR™ Endovascular Catheter is a device intended for the localized infusion of physician specified fluids, including thrombolytics, into the peripheral vasculature.

The BASHIR™ N-X Endovascular Catheter is a device intended for the localized infusion of physician specified fluids, into the peripheral vasculature, including the pulmonary arteries.

Need more details? Contact us.

We are here to assist. Contact us by phone, email or via our social media channels.